Evidence map›Paper›PMID 32757991›Full record

ArticleAnnals of Saudi medicine

Mai Alalawi, Seba Aljahdali, Bashaer Alharbi, Lana Fagih, Raghad Fatani, Ohoud Aljuhani

Open access · diamondAbstract readEvaluation Study
In one paragraph

Article in Annals of Saudi medicine. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.1field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Clinical characteristics and risk factors ofFrontiers in pediatrics · 2025
    Article
  4. Article
  5. Article
  6. Epidemiology ofSaudi medical journal · 2024
    Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Mai AlalawiFrom the Department of Pharmacy Practice, Faculty of Pharmacy, King Abdulaziz University, Jeddah, Saudi Arabia.
Seba AljahdaliFrom the Department of Pharmacy Practice, Faculty of Pharmacy, King Abdulaziz University, Jeddah, Saudi Arabia.
Bashaer AlharbiFrom the Faculty of Pharmacy, Umm Al-Qura University, Makkah, Saudi Arabia.
Lana FagihFrom the Department of Pharmacy Practice, Faculty of Pharmacy, King Abdulaziz University, Jeddah, Saudi Arabia.
Raghad FataniFrom the Department of Pharmacy Practice, Faculty of Pharmacy, King Abdulaziz University, Jeddah, Saudi Arabia.
Ohoud AljuhaniFrom the Department of Pharmacy Practice, Faculty of Pharmacy, King Abdulaziz University, Jeddah, Saudi Arabia.
King Abdulaziz University · SAUmm al-Qura University · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

background

objectivesEstimate the prevalence of

designRetrospective record review.

settingTertiary academic medical center in Jeddah. PATIENTS AND

methodsEligible patients were adults (≥18 years old) with confirmed

main outcome measuresPrevalence rate and types of risk factors. SAMPLE SIZE: Of 1886 records, 129 patients had positive lab results and met the inclusion criteria.

resultsThe prevalence of

conclusionThe overall LIMITATIONS: Single center and retrospective design. CONFLICT OF INTEREST: None.

Indexed as

Academic Medical CentersAdultAgedAnti-Bacterial AgentsClostridium InfectionsCross InfectionDiarrheaFemaleHumansMaleMiddle AgedPrevalenceProton Pump InhibitorsRetrospective StudiesRisk FactorsSaudi ArabiaAnti-Bacterial AgentsProton Pump Inhibitors

Identifiers

PMID32757991
PMCPMC7410223
OpenAlexW3047507998

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.